Plain-English translation of NCT05610501 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at a less invasive way to diagnose pelvic tumors in women. Instead of requiring surgery under general anesthesia, doctors use ultrasound imaging to guide a special needle that collects a small tissue sample from the tumor. The study will help determine whether this needle biopsy technique is reliable, safe, and effective at providing the information doctors need to choose the right treatment.
Many women with pelvic tumors currently need surgery to get a tissue diagnosis, which requires general anesthesia, a hospital stay, and carries risks of surgical complications. This study explores whether a needle biopsy guided by ultrasound can provide the same accurate diagnosis while being safer, faster, and less costly for patients.
If you qualify, a trained doctor will use ultrasound imaging to guide a needle biopsy of your pelvic mass—a procedure that takes less time than surgery and typically does not require general anesthesia. After the biopsy, you will be asked about your pain level and experience. The study team will follow up with you by phone about 6 weeks later to check for any complications and confirm you recovered well.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Belgium
Czechia
Italy
Sweden
Sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
UZ Leuven, Leuven, Belgium, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment target
~200 participants
Started
May 2021
Primary completion
April 2025
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Wouter Froyman, MD, PHD
Universitaire Ziekenhuizen KU Leuven